Cosyntropin and Vitamins drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cosyntropin (cosyntropin) and Vitamins (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e). Common drug interactions include blood creatinine increased among females and back pain among males.

The phase IV clinical study analyzes what interactions people have when they take Cosyntropin and Vitamins. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Cosyntropin?

Cosyntropin has active ingredients of cosyntropin. eHealthMe is studying from 222 Cosyntropin users. Check the latest studies of Cosyntropin.

What is Vitamins?

Vitamins has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 122,456 Vitamins users. Check the latest studies of Vitamins.

On Jul, 11, 2026

18 people who take Cosyntropin and Vitamins together, and have interactions are studied.

Cosyntropin and Vitamins drug interactions.

What are the common drug interactions of Cosyntropin and Vitamins, by gender? *:

female:

Blood creatinine increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac failure
Cough
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Death
Encephalopathy (functioning of the brain is affected by some agent or condition)
Hyperbilirubinaemia (excess of bilirubin in the blood)
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)

male:

Back pain
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Bile duct stone
Bladder transitional cell carcinoma (types of bladder cancer)
Bloody discharge
Cholangitis (infection of the bile duct)
Cholangitis acute (rapid infection of bile duct)
Cholangitis sclerosing (infection and obstruction of bile duct)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Chronic kidney disease

What are the common drug interactions of Cosyntropin and Vitamins, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
Foetal growth restriction (poor growth of a baby while in the mother's womb during pregnancy)
Hypoglycaemia (deficiency of glucose in the bloodstream)
Hypoglycaemia neonatal (deficiency of glucose in the bloodstream in neonatal)

30-39:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Chronic kidney disease
Emotional distress
Pain
Partner stress
Renal failure (kidney dysfunction)

40-49:

n/a

50-59:

Parkinsonism (degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination)

60+:

Back pain
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Blood creatinine increased
Bloody discharge
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac failure
Cholangitis (infection of the bile duct)
Cholangitis acute (rapid infection of bile duct)
Cholangitis sclerosing (infection and obstruction of bile duct)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

What are the existing conditions these people have? *

Pain: 7 people, 38.89%
Sepsis (a severe blood infection that can lead to organ failure and death): 6 people, 33.33%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 27.78%
Hyperemesis Gravidarum (a condition characterized by severe nausea, vomiting, weight loss, and electrolyte disturbance): 5 people, 27.78%
High Blood Pressure: 5 people, 27.78%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 4 people, 22.22%
Thrombocytopenia (decrease of platelets in blood): 4 people, 22.22%
Septic Shock (shock due to blood infection): 4 people, 22.22%
Hypoparathyroidism (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood): 3 people, 16.67%
Hypersensitivity: 3 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Cosyntropin and Vitamins?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously